Medicare Enrolled
Dr. Leah Press, M.D.
Dermatology · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Press from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Press?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Press
Dr. Leah Press is a dermatology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Press performed 7,785 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Press received a total of $9,681 from 46 pharmaceutical and/or device companies across 471 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Press is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in CA
$9,681 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,785
Medicare services
Top 14% in CA for dermatology
Not available
Unique patients (not deduplicated)
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,359 | $65 | $114 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,201 | $6 | $15 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
1,111 | $59 | $125 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
424 | $131 | $206 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
385 | $87 | $160 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $44 | $64 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
340 | $94 | $141 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
336 | $78 | $125 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
320 | $40 | $92 |
| High dose rate electronic brachytherapy, external | 279 | $131 | $223 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
248 | $1 | $10 |
| External heat therapy for cancer cells, 4 cm depth or less This procedure uses externally generated heat to raise the temperature of cancer cells to a depth of 4.0 cm or less. |
213 | $421 | $644 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
172 | $223 | $325 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
90 | $304 | $466 |
| Destruction of skin growth, 15 or more growths | 86 | $107 | $177 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
86 | $5 | $10 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
82 | $225 | $400 |
| Cast removal The procedure involves cutting off or removing a body cast, boot, or gauntlet. |
67 | $28 | $80 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
63 | $34 | $70 |
| Strapping, unna boot | 63 | $46 | $81 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
55 | $89 | $145 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
47 | $40 | $70 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
43 | $115 | $340 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $11 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $106 | $210 |
| Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length. |
34 | $339 | $501 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
31 | $103 | $150 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
31 | $43 | $90 |
| Complicated wound repair, 2.6-7.5 cm A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet. |
29 | $388 | $568 |
| Skin cancer removal, face/ears/eyes/nose/lips, 2.1-3.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 2.1 and 3.0 centimeters. |
27 | $130 | $380 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
25 | $215 | $296 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
25 | $36 | $77 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
20 | $68 | $178 |
| Complicated wound repair of trunk, 2.6-7.5 cm A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length. |
20 | $321 | $470 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
19 | $63 | $110 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $68 | $140 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
13 | $54 | $143 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,681
Total received (2018-2024)
Avg $1,383/year across 7 years
Top 17% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
471
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,094
2023
$1,535
2022
$1,633
2021
$1,548
2020
$1,082
2019
$1,452
2018
$1,336
Payments by company (2024)
SUN PHARMACEUTICAL INDUSTRIES INC.
$219
Incyte Corporation
$179
ABBVIE INC.
$147
Janssen Biotech, Inc.
$117
E.R. Squibb & Sons, L.L.C.
$84
Regeneron Healthcare Solutions, Inc.
$75
Galderma Laboratories, L.P.
$52
PFIZER INC.
$37
REVANCE THERAPEUTICS, INC.
$33
UCB, Inc.
$28
Lilly USA, LLC
$28
Amgen Inc.
$28
Dermavant Sciences, Inc.
$26
LEO Pharma Inc.
$24
Arcutis Biotherapeutics, Inc.
$19
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$991
ABBVIE INC.
$910
Novartis Pharmaceuticals Corporation
$701
Sun Pharmaceutical Industries Inc.
$691
Incyte Corporation
$597
LEO Pharma Inc.
$557
Merz North America, Inc.
$491
AbbVie Inc.
$455
SUN PHARMACEUTICAL INDUSTRIES INC.
$450
PFIZER INC.
$436
Regeneron Healthcare Solutions, Inc.
$387
Lilly USA, LLC
$352
Ortho Dermatologics, a division of Bausch Health US, LLC
$285
Genentech USA, Inc.
$225
MERZ NORTH AMERICA, INC.
$224
Galderma Laboratories, L.P.
$186
AbbVie, Inc.
$186
E.R. Squibb & Sons, L.L.C.
$168
UCB, Inc.
$157
EPI Health, LLC
$142
Amgen Inc.
$115
GENZYME CORPORATION
$108
Biofrontera Inc.
$105
DUSA Pharmaceuticals, Inc.
$100
Dermavant Sciences, Inc.
$97
VYNE Pharmaceuticals Inc.
$92
Almirall LLC
$49
Celgene Corporation
$48
Janssen Scientific Affairs, LLC
$40
REVANCE THERAPEUTICS, INC.
$33
Fresenius Kabi USA, LLC
$31
Aclaris Therapeutics, Inc.
$26
Nabriva Therapeutics, plc
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
ORGANOGENESIS INC.
$22
STRATA Skin Sciences, Inc.
$22
GlaxoSmithKline, LLC.
$19
Promius Pharma LLC
$19
Arcutis Biotherapeutics, Inc.
$19
Solta Medical, a division of Bausch Health US, LLC
$18
Alfasigma USA, Inc.
$18
Merck Sharp & Dohme Corporation
$16
Encore Dermatology Inc.
$15
Mylan Pharmaceuticals Inc.
$14
Allergan Inc.
$13
PruGen, Inc. Pharmaceuticals
$3
Top 3 companies account for 26.9% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX COSMETIC · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DERMATITIS - DISEASE · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · HUMIRA · Humira · ICLUSIG · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · LEVULAN KERASTICK · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ODOMZO · OPZELURA · Odomzo · Otezla · Puraply Antimicrobial · REMICADE · RHOFADE · RINVOQ · SHINGRIX · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sivextro · Sotyktu · TALTZ · TREMFYA · TRIANEX 0.05% · Tremfya · VTAMA · WYNZORA · Winlevi · XEOMIN · XIMINO · XTRAC · Xeomin · Xolair · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
27
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
FRESNO SURGICAL HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Press is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Press experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Press performed 1,359 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Press receive payments from pharmaceutical companies?
Yes. Dr. Press received a total of $9,681 from 46 companies across 471 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Press's costs compare to other dermatologists in Fresno?
Dr. Press's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Press) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Fresno
Browse dermatologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology